Endometrial Ablation Market value is projected to increase at a CAGR of around 7.3% from 2023 to 2033

 The Endometrial Ablation Market revenues were estimated at US$ 3.4 Bn in 2023 and are anticipated to grow at a CAGR of 7.3% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 6.8 Billion. The aggregate revenue from US and China was US$ 1.4 Billion in 2022.

With the advent of minimally invasive endometrial ablation treatments, the endometrium can be destroyed in a more expedient, outpatient setting. This operation is less dangerous and technically straightforward to carry out.

To learn more about this report @ https://www.futuremarketinsights.com/reports/endometrial-ablation-market

The International Federation of Gynaecology and Obstetrics estimates that between 3% and 30% of reproductive-aged women are affected by Abnormal Uterine Bleeding. Women's treatment plans have become the key focus of the general health industry in the modern world. Governments and private organizations around the world have placed women's health at the center of their wellbeing race.

In India, such as in many other locations, women are eligible for several tax benefits and exemptions under the provisions of several sections of the tax code. Women's healthcare initiatives may promote the effectiveness of treatment alternatives, which will boost the market.

Uterine Ablation is a medical procedure that involves the removal or destruction of the lining of the uterus, known as the endometrium. This procedure is often used to treat heavy or prolonged menstrual bleeding, and can be an alternative to a hysterectomy.

Competitive Landscape

  • Medtronic
  • CooperSurgical Inc.
  • Boston Scientific Corp.
  • Ethicon, Inc.
  • Olympus Corp.
  • Richard Wolf GmbH
  • AngioDynamics
  • Hologic, Inc.
  • Minerva Surgical, Inc.

A few of the recent developments in the market are:

  • In February 2021, CooperSurgical, a division of CooperCompanies, has acquired Aegea Medical, nearly a year after the company received FDA approval for its Mara water vapor ablation system for severe menstrual bleeding.
  • In May 2019, Medtronic Plc announced a partnership with Koninklijke Philips N.V. This collaboration is projected to result in an integrated cryoablation solution that is cutting-edge in terms of image guidance.
  • In April 2021, Olympus Corporation relocated its Therapeutic Solutions Division's worldwide headquarters from Tokyo to the United States in order to gain better access to the medical industry and earn more revenue through expanded commercial prospects.
  • In June 2021, Boston Scientific purchased the remaining shares of FARAPULSE. Boston Scientific's electrophysiology sector was bolstered by the acquisition, which added pulsed-field ablation technology to the company's offerings.

Market Segments Covered in Endometrial Ablation Market Analysis

By Type:

  • Devices
    • Cryoablation
    • Radiofrequency Ablation
    • Hydrothermal Ablation
    • Thermal Balloon
    • Microwave Energy
  • Procedures

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers

Comments

Post a Comment

Popular posts from this blog

Orthopedic Trauma Devices Market is projected to reach a valuation of US$ 21.2 Bn by 2033 | FMI

Image
  The net worth of the Orthopaedic Trauma Devices Market is expected to increase from US$ 10.7 billion in 2023 to more than US$ 21.2 billion by 2033. From 2023 to 2033, the orthopaedic trauma device market is expected to grow at a 7.1% CAGR . To learn more about this report @ https://www.futuremarketinsights.com/reports/orthopedic-trauma-devices-market With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Orthopedic Trauma Devices market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Orthopedic Trauma Devices market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision. Over the past decade, healthcar
Read more

Insulin Pen Market is forecasted to surpass US$ 46.9 Bn by 2031

Image
Diabetes is becoming more common as poor lifestyle choices continue to be prominent around the world. Insulin pens are a widely used method of treating diabetic individuals. Given this, Future Market Insights predicts that insulin pen sales will reach US$ 30,407 million in 2021. Insulin pens are used by diabetes patients to avoid problems including cardiovascular diseases that may arise from this lifestyle-based ailment. To overcome problems related to conventional methods of insulin administration, insulin pens make the process easier and faster. Get More Information on this Report @ https://www.futuremarketinsights.com/reports/insulin-pens-market According to the WHO, approximately 1.2 million deaths were caused due to diabetes in 2019 globally. To reduce the number of deaths or sufferings due to diabetes, the development of innovative techniques and products for the treatment and maintenance of diabetes is essential. Type 2 diabetes cases are common, but it can be prevented or de
Read more

Molecular Biology Enzymes, Kits & Reagents Market Size, Share, Growth, Forecast through 2032

Image
  According to a recent Future Market Insights report, the global Molecular Biology Enzymes, Kits & Reagents Market will grow dramatically between 2022 and 2032. By 2032, global sales of molecular biology enzymes, kits, and reagents are expected to total approximately US$ 48,476.41 million. Technological Advancements Leading to Enhanced Efficiency & Greater Precision of Molecular Biology Enzymes, Kits & Reagents The manufacturers of molecular biology enzymes, kits, and reagents have contributed significantly to technical breakthroughs by focusing on creating cutting-edge goods in an effort to diversify their product offerings. The cutting-edge items support the study procedures by providing features like increased precision and efficiency. One of the best instances of this is Thermo Fisher Scientific, Inc.’s SMART Digest Kit, which was created specifically for biopharmaceutical and proteomic applications. This kit reduces the time required for sample preparation while
Read more